Citric Acid

Citric Acid

SCHEMBL3597963

O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Ru+3]

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BHRH2IMPA1

The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA4 P22748 3/20 0.89
ALDH1A1 P00352 1/20 0.33
CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Citric Acid SCHEMBL29496932 0.97 CA4 (0.84) CA4ALDH1A1CASP1
Citric Acid SCHEMBL29496933 0.97 CA4 (0.84) CA4ALDH1A1CASP1
Citric Acid SCHEMBL42945 0.97 CA4 (0.94) CA4ALDH1A1CASP1
Citric Acid SCHEMBL29587574 0.97 CA4 (0.94) CA4ALDH1A1CASP1
Citric Acid SCHEMBL1291555 0.97 CA4 (0.94) CA4ALDH1A1CASP1
Citric Acid SCHEMBL22686437 0.97 CA4 (0.94) CA4ALDH1A1CASP1
Citric Acid SCHEMBL23012792 0.94 CA4 (0.89) CA4ALDH1A1CASP1
Citric Acid SCHEMBL20668544 0.94 CA4 (0.89) CA4ALDH1A1CASP1
Citric Acid SCHEMBL1458270 0.94 CA4 (0.89) CA4ALDH1A1CASP1
Citric Acid SCHEMBL21555662 0.94 CA4 (0.89) CA4ALDH1A1CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250347011-A1 BIMETALLIC RUTHENIUM-COBALT ALLOY ELECTROCATALYST FOR HYDROGEN PRODUCTION KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-11-13 US claimed
US-20250340433-A1 RUTHENIUM-DOPED ALUMINA-SUPPORTED COBALT/NICKEL CATALYST FOR AMMONIA DECOMPOSITION TO HYDROGEN AND NITROGEN KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-11-06 US claimed
CN-109046412-B Catalyst for preparing maleic anhydride by oxidizing n-butane and preparation method thereof 常州新日催化剂股份有限公司 2021-05-25 CN claimed
US-12630488-B2 Hydrocarbon production system, and production method and operation method thereof OSAKA GAS CO., LTD. (JP) 2026-05-19 US disclosed
US-12529151-B2 Electrolysis cell unit, electrolysis cell device, hydrocarbon production system, and production method and use method of electrolysis cell unit OSAKA GAS CO., LTD. (JP) 2026-01-20 US disclosed
US-20250387779-A1 METHOD FOR AMMONIA DECOMPOSITION USING CARBON MATERIAL SUPPORTED METAL CATALYST SAUDI ARABIAN OIL CO (SA) 2025-12-25 US disclosed
US-20250347011-A1 BIMETALLIC RUTHENIUM-COBALT ALLOY ELECTROCATALYST FOR HYDROGEN PRODUCTION KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-11-13 US disclosed
US-20250340433-A1 RUTHENIUM-DOPED ALUMINA-SUPPORTED COBALT/NICKEL CATALYST FOR AMMONIA DECOMPOSITION TO HYDROGEN AND NITROGEN KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-11-06 US disclosed
US-12146065-B2 Water-based ceramic dye CEVP SAGL (CH) 2024-11-19 US disclosed
US-20240165592-A1 Method for Producing Reverse Water-Gas Shift Catalyst, Reverse Water-Gas Shift Catalyst, Electrolysis Reaction System, Hydrocarbon Production System, and Method for Using Reverse Water-Gas Shift Catalyst OSAKA GAS CO., LTD. (JP) 2024-05-23 US disclosed
EP-4316655-A1 METHOD FOR MANUFACTURING REVERSE WATER-GAS SHIFT CATALYST, REVERSE WATER-GAS SHIFT CATALYST, ELECTROLYTIC REACTION SYSTEM, HYDROCARBON MANUFACTURING SYSTEM, AND METHOD FOR USING REVERSE WATER-GAS SHIFT CATALYST Osaka Gas Co., Ltd. (JP) 2024-02-07 EP disclosed
US-20090182160-A1 Vanadium Compositions And Methods of Making the Same SYMYX TECHNOLOGIES, INC. (US) 2009-07-16 US disclosed
US-20090029852-A1 Molybdenum Compositions And Methods of Making the Same FREESLATE, INC. 2009-01-29 US disclosed
US-20090011930-A1 Cerium Compositions and Methods of Making the Same SYMYX TECHNOLOGIES, INC. (US) 2009-01-08 US disclosed
EP-1879833-A2 HIGH SURFACE AREA METAL AND METAL OXIDE MATERIALS AND METHODS OF MAKING SAME Symyx Technologies, Inc. (US) 2008-01-23 EP disclosed
WO-2006119311-A2 HIGH SURFACE AREA METAL AND METAL OXIDE MATERIALS AND METHODS OF MAKING SAME SYMYX TECHNOLOGIES, INC. (US) 2006-11-09 WO disclosed
US-5509189-A Method for making an electrochemical cell MASSACHUSETTS INSTITUTE OF TECHNOLOGY, A MA CORP. (US) 1996-04-23 US disclosed
US-5403461-A Solid electrolyte-electrode system for an electrochemical cell MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1995-04-04 US disclosed
WO-1994020997-A1 SOLID ELECTROLYTE-ELECTRODE SYSTEM FOR AN ELECTROCHEMICAL CELL MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1994-09-15 WO disclosed
US-4962267-A OF OLEFIN FEEDSTOCK USING A CATALYST COMPRISING RUTHENIUM OXIDE AND ALKALI METAL OXIDE SHELL OIL COMPANY (US) 1990-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12529151-B2 Electrolysis cell unit, electrolysis cell device, hydrocarbon production system, and production method and use method of electrolysis cell unit SLC9A2, EPCAM, SLC9A1 CA4 214/4885ALDH1A1 3041/4885CASP1 868/4885
US-12630488-B2 Hydrocarbon production system, and production method and operation method thereof HAO2, HMOX2, HMOX1 CA4 844/4885ALDH1A1 3681/4885CASP1 2282/4885
US-20250387779-A1 METHOD FOR AMMONIA DECOMPOSITION USING CARBON MATERIAL SUPPORTED METAL CATALYST ARG2, MT-CO2, ARG1 CA4 792/4885ALDH1A1 4507/4885CASP1 4490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.